UK Antimicrobial Registry (UKAR) Study update by
@reb_parr et al as of Nov 2023:
52 patients recruited across 9 UK sites, dalbavancin most prescribed.
The study aims to understand use, effectiveness & safety of recently licensed antimicrobials.
@BSACandJAC doi.org/10.1093/jacamr/dlad1โฆ